Written by The Microcatheters Market is growing as minimally invasive procedures become increasingly important in cardiovascular, neurovascular, peripheral vascular, oncology, and urology treatments. Microcatheters allow physicians to navigate small and complex blood vessels with greater precision, supporting the delivery of drugs, contrast agents, embolic materials, and other therapeutic devices. Rising demand for less invasive interventions is contributing to market expansion.
Technological advancements are improving microcatheter flexibility, tracking ability, and navigational performance. Delivery microcatheters accounted for 37.2% of global revenue in 2025, while steerable microcatheters are projected to grow at a 5.4% CAGR through 2035. Hydrophilic coatings, braided-polymer construction, and improved tip designs are helping manufacturers develop products for increasingly complex vascular procedures.
North America led the market with approximately 44% of global revenue in 2025, supported by established interventional healthcare infrastructure and high procedure volumes. Asia-Pacific is expected to be the fastest-growing regional market, with a projected 6.5% CAGR through 2035, driven by expanding hospital infrastructure and increasing adoption of minimally invasive procedures.
The global market was valued at USD 1.87 billion in 2025 and is projected to reach USD 2.98 billion by 2035, registering a 4.35% CAGR during 2026–2035. Growing stroke and cardiovascular intervention volumes, robotic-assisted catheterization, and continued advances in microcatheter materials are expected to create further opportunities for market participants.